Purification of human erythrocyte proteolytic enzyme responsible for degradation of oxidant-damaged hemoglobin. Evidence for identifying as a member of the multicatalytic proteinase family.
Exposure of human red cells to oxidants such as phenylhydrazine, 2,4-dimethylphenylhydrazine and 4-hydrazinobenzoic acid stimulates the proteolysis of hemoglobin as evidenced by the increase in the rate of the free alanine and acid soluble amino groups released. An enzyme responsible for proteolytic degradation of oxidized hemoglobin, was purified from cytosolic fraction of erythrocytes by a DEAE-batch procedure followed by gel-filtration and ion-exchange chromatography. The final enzyme preparation produces a single band in non-denaturing polyacrylamide gel electrophoresis, and eight different bands of 23-32 kDa when subjected to polyacrylamide gel electrophoresis under denaturing conditions. The native enzyme has a molecular mass of about 700 kDa as estimated by gel filtration. The enzyme, unable to hydrolyze native hemoglobin, cleaves phenylhydrazine-treated hemoglobin into small peptides without free amino acid release. In addition, the enzyme shows an endopeptidase activity towards synthetic peptides having a tyrosine or an arginine in the P1 position, whereas it does not hydrolyze shorter peptides and those with a proline in the P1 or P2 position. The proteolytic activity of the enzyme against oxidized hemoglobin is inhibited by chymostatin and p-chloromercuribenzoate, while it is stimulated by N-ethylmaleimide and epoxysuccinylleucylamido-(4-guanidino)butane (E-64). The peptidase activity assayed on succinyl-Leu-Leu-Val-Tyr-MCA is inhibited by chymostatin, hemin, N-ethylmaleimide and p-chloromercuribenzoate. The results obtained show that in human erythrocytes oxidized hemoglobin is cleaved into peptides by a high molecular mass proteinase identified as a member of the multicatalytic proteinase family. It is also suggested that the complete degradation of oxidized hemoglobin to free amino acids requires the involvement of a further proteolytic enzyme(s) which remain(s) to be identified.
Sacchetta
P
P
Institute of Scienze Biochimiche, Faculty of Medicine, University of Chieti, Italy.
Battista
P
P
Santarone
S
S
Di Cola
D
D
D000595:Amino Acid Sequence; D002845:Chromatography; D003546:Cysteine Endopeptidases / Q000097:blood* / Q000302:isolation & purification; D003600:Cytosol / Q000201:enzymology; D004591:Electrophoresis, Polyacrylamide Gel; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology*; D005033:Ethylmaleimide / Q000494:pharmacology; D006427:Hemin / Q000494:pharmacology; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D008969:Molecular Sequence Data; D008970:Molecular Weight; D009097:Multienzyme Complexes / Q000097:blood* / Q000302:isolation & purification; D009842:Oligopeptides / Q000494:pharmacology; D010446:Peptide Fragments / Q000097:blood; D010659:Phenylhydrazines / Q000494:pharmacology; D011480:Protease Inhibitors; D046988:Proteasome Endopeptidase Complex; D013379:Substrate Specificity
D006454:Hemoglobins; D006834:Hydrazines; D009097:Multienzyme Complexes; D009842:Oligopeptides; D010446:Peptide Fragments; D010659:Phenylhydrazines; D011480:Protease Inhibitors; C030299:phenylhydrazine; D006427:Hemin; C002101:chymostatin; D003546:Cysteine Endopeptidases; D046988:Proteasome Endopeptidase Complex; D005033:Ethylmaleimide